Bridget E. Shields

Bridget E. Shields

Dermatology
1 S Park St
Suite 501
Madison, WI 53715

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease.

Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease.

Journal: JAMA dermatology
Published: May 27, 2026

Discovery of metabolites produced by reactions between central carbon metabolites and cysteine that mark inflammatory macrophages.

Discovery of metabolites produced by reactions between central carbon metabolites and cysteine that mark inflammatory macrophages.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Granuloma annulare: An updated review of epidemiology, molecular pathogenesis, and management.

Granuloma annulare: An updated review of epidemiology, molecular pathogenesis, and management.

Journal: Journal of the American Academy of Dermatology
Published: March 11, 2026

Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields.

Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields.

Journal: Cutis
Published: January 12, 2026

Sarcoidosis in focus: spatial transcriptomics offers a new perspective.

Sarcoidosis in focus: spatial transcriptomics offers a new perspective.

Journal: American journal of respiratory and critical care medicine
Published: November 12, 2025

Granulomatous tattoo reaction associated with poly (lactic-co-glycolic acid) (PLGA) microsphere-based naltrexone injections.

Granulomatous tattoo reaction associated with poly (lactic-co-glycolic acid) (PLGA) microsphere-based naltrexone injections.

Journal: JAAD case reports
Published: June 17, 2025

Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease: A Consensus Statement.

Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease: A Consensus Statement.

Journal: JAMA dermatology
Published: May 07, 2025

Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus.

Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus.

Journal: Cutis
Published: February 13, 2025

Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare.

Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare.

Journal: The Journal of investigative dermatology
Published: January 27, 2025

Benefits of High-Dose Vitamin D in Managing Cutaneous Adverse Events Induced by Chemotherapy and Radiation Therapy.

Benefits of High-Dose Vitamin D in Managing Cutaneous Adverse Events Induced by Chemotherapy and Radiation Therapy.

Journal: Cutis
Published: October 16, 2024

Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.

Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.

Journal: Cutis
Published: July 31, 2024

Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease.

Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease.

Journal: Cutis
Published: May 31, 2024
Showing 1-12 of 71

Last Updated: 09/26/2026